Topic
Interventional Oncology (IO)
127 Podcasts • 60 Cases • 9 Courses on BackTable
Hear how experienced clinicians in Interventional Oncology (IO) approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 676 • 18 Sept 2026
Use of Tunneled Catheters for Ascites & Effusions Management
When is it time to move from repeat drainage to a tunneled catheter for managing pleural effusions or ascites? On this episode of BackTable Podcast, Dr. Neil Jain interviews Dr. Marco Ertreo, interventional radiologist and IR residency program director at Strong Memorial Hospital, University of Rochester, about best practices for tunneled catheter management in both the chest and abdomen. They discuss the triggers for placing a tunneled catheter, patient selection, placement technique, home drainage protocols, complication management, and the unique considerations for malignant versus cirrhotic ascites.
More on Interventional Oncology (IO)
Loading recent podcasts…
Vascular & IR # 676
Sep 17, 2026
with Dr. Marco Ertreo, Dr. Neil Jain
When is it time to move from repeat drainage to a tunneled catheter for managing pleural effusions or ascites? On this...
Industry # 107
Aug 31, 2026
with Dr. Gregg Khodorov, Anish Parikh
What does a personal learning system look like when you have to build it yourself, in your first year out of training?...
Vascular & IR # 657
Jun 22, 2026
with Dr. Beau Toskich, Dr. Juan Gimenez, Dr. Tyler Sandow
What do you do when Y-90 doesn’t deliver the results you expected? In this episode of the 2026 HCC Creator Weekend™,...
1,600+ listens
Tumor Board # 66
Jun 15, 2026
with Dr. Gregory Botta, Dr. Zach Berman, Dr. Rebekah White
How do seasoned clinicians navigate the complex web of complications that accompany pancreatic cancer? In this episode...
Vascular & IR # 673
Sep 7, 2026
with Dr. Ryan Hickey, Dr. Tyler Sandow, Dr. Venkatesh Krishnasamy
The key to personalizing Y90 may not just be treating the tumor, but understanding how much radiation a patient can...
2,100+ listens
Vascular & IR # 659
Jun 29, 2026
with Dr. Beau Toskich, Dr. Lingling Du, Dr. Tyler Sandow
How do you safely combine locoregional and systemic therapies to treat hepatocellular carcinoma (HCC) when traditional...
1,400+ listens
Vascular & IR # 655
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone, Dr. Zach Berman
How is Y90 radioembolization rewriting the rules for managing large HCC tumors and creating new curative-intent...
1,700+ listens
Vascular & IR # 653
Jun 8, 2026
with Dr. Beau Toskich, Dr. Christopher Malone, Dr. Venkatesh Krishnasamy
How can targeted liver radiation unlock surgical or transplant options for tough hepatocellular carcinoma (HCC) cases?...
1,600+ listens
VI Case
Sep 16, 2026
with Dr. Beau Toskich, Dr. Juan Gimenez and Dr. Tyler Sandow
VI Case
Jul 27, 2026
with Dr. Trushar Patel and Dr. Sabeen Dhand
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Sep 16, 2026
with Dr. Beau Toskich, Dr. Juan Gimenez and Dr. Tyler Sandow
VI Case
Jul 26, 2026
with Dr. Abhishek Kumar (VIR) and Dr. Sabeen Dhand
VI Case
Apr 29, 2026
with Dr. Christopher Malone, Dr. Kirema Garcia-Reyes and Dr. Venkatesh Krishnasamy
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
Tumor Board Course
2 CME/CE credits, 2.5 hours, 26 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.